Alfonso Zulueta
About Alfonso Zulueta
Professional Background
Alfonso Zulueta recently transitioned to the role of Independent Director after a long and distinguished career at Eli Lilly and Company. During his tenure at Eli Lilly, he served in various critical roles including Vice President of Global Marketing, President of Global Oncology and Critical Care Products, and most recently, President of International. He was also a corporate officer and a member of the Executive Committee at the company. His comprehensive experience in the pharmaceutical industry spans over three decades.
Current Roles and Responsibilities
Currently, Alfonso Zulueta holds several significant positions in the business world. He serves as the Non-Executive Chairman of the board of directors at Interpharma Investments Limited. Additionally, he is the president and CEO of CZ Ventures, a company focused on start-up investments. Zulueta is also an active member of the board of directors at Glooko, CTS Corporation, and Bridge PayDay Solutions.
Education and Expertise
Alfonso Zulueta holds an undergraduate degree in Economics from De La Salle University in Manila, where he was recently honored with the 2023 Outstanding Alumnus Award. He furthered his education with an MBA in Marketing/Finance from the University of Virginia, Darden School of Business. His academic background has played a pivotal role in shaping his expertise in both the pharmaceutical industry and business management.
Industry Contributions
Throughout his career, Alfonso Zulueta has taken on various leadership roles that have helped shape the pharmaceutical industry. He has served as a member of the board of the European Federation of Pharmaceutical Industries and Associations. Additionally, he has contributed to international business relations through his previous involvement with the U.S.-Japan Business Council.